Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Endometrial Neoplasms 3Breast Neoplasms 3Breast Carcinoma In Situ 2Vitamin D Deficiency 1Polycystic Ovary Syndrome 1Paget's Disease, Mammary 1Kidney Neoplasms 1Hot Flashes 1Endometrial Adenocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1

Interventions

Paclitaxel 11Carboplatin 8Radiotherapy 7Letrozole 7Cyclophosphamide 7Trastuzumab 5Chemotherapy, Adjuvant 5Doxorubicin 4Brachytherapy 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4atamestane 3Toremifene 3Tamoxifen 3Radiotherapy, Conformal 3Magnetic Resonance Spectroscopy 3Epirubicin 3Docetaxel 3Cryosurgery 3Cisplatin 3pertuzumab 2Surgical Procedures, Operative 2Radiation 2Lapatinib 2Fulvestrant 2Estrogen Receptor Modulators 2Cryotherapy 2Capecitabine 2Biopsy 2Aromatase Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ductal, Breast × Medroxyprogesterone × Clear all
NCT00026286 2023-06-15

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡